• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Previous Issues
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Parasitologists United Journal
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 18 (2025)
Volume Volume 17 (2024)
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 16 (2023)
Volume Volume 15 (2022)
Volume Volume 14 (2021)
Volume Volume 13 (2020)
Volume Volume 12 (2019)
Volume Volume 11 (2018)
Volume Volume 10 (2017)
Abaza, S. (2024). Recent advances in identification of potential drug targets and development of novel drugs in parasitic diseases: Part V: The value of natural products in drug discovery: Helminths. Parasitologists United Journal, 17(2), 57-73. doi: 10.21608/puj.2024.292672.1250
Sherif Abaza. "Recent advances in identification of potential drug targets and development of novel drugs in parasitic diseases: Part V: The value of natural products in drug discovery: Helminths". Parasitologists United Journal, 17, 2, 2024, 57-73. doi: 10.21608/puj.2024.292672.1250
Abaza, S. (2024). 'Recent advances in identification of potential drug targets and development of novel drugs in parasitic diseases: Part V: The value of natural products in drug discovery: Helminths', Parasitologists United Journal, 17(2), pp. 57-73. doi: 10.21608/puj.2024.292672.1250
Abaza, S. Recent advances in identification of potential drug targets and development of novel drugs in parasitic diseases: Part V: The value of natural products in drug discovery: Helminths. Parasitologists United Journal, 2024; 17(2): 57-73. doi: 10.21608/puj.2024.292672.1250

Recent advances in identification of potential drug targets and development of novel drugs in parasitic diseases: Part V: The value of natural products in drug discovery: Helminths

Article 1, Volume 17, Issue 2, August 2024, Page 57-73  XML PDF (897.36 K)
Document Type: Review Article
DOI: 10.21608/puj.2024.292672.1250
View on SCiNiTO View on SCiNiTO
Author
Sherif Abaza email
Department of Medical Parasitology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt
Abstract
Almost all the current drugs used to treat neglected tropical diseases have some drawbacks including
cytotoxicity, limited availability, and the emergence of resistant strains. The clinical significance of a natural
product was recognized as a novel target against pathogens by identifying its mechanisms of action. Such
products are commonly used for treating severe parasitic diseases such as malaria, leishmaniasis, Chagas'
disease, schistosomiasis, and filariasis. A significant drawback of natural products is their limited supply.
However, sustainable production is possible by utilizing bioengineering technology to facilitate the
biosynthesis of derivatives with similar biological activities and discover new families of natural products by
cultivating bacteria, fungi, endophytes, and marine creatures. Advances in genetic engineering technology,
i.e., molecular farming, enabled investigators to focus on developing novel safe drugs from natural products.
This review aims to highlight recent advances in discovering novel drugs extracted from natural products of
herbal and marine sources for treating helminthic diseases.
Keywords
drug discovery; essential oils; helminths; marine source; natural products; propolis
Statistics
Article View: 143
PDF Download: 677
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.